​​​​Global Coalition on Aging and Pfizer Medical Grants Partner to Tackle Vaccine Hesitancy in Super-Aging Japan

The unique partnership supports innovative research to increase use of recommended vaccines among Japan’s older adult population

New York, NEW YORK (February 17, 2021) – The Global Coalition on Aging and Pfizer Global Medical Grants announced today the launch of the first of its grant projects under the Japan-focused VALUE Initiative (Vaccines for All: Longevity Unleashed for Everyone), which has provided up to $1 million USD in grant awards. Grant recipients include Keio University, the Health and Global Policy Institute (HGPI), and the International Longevity Centre-UK. The three VALUE projects are poised to generate critical insights for both policy and practice about how to increase vaccine use among older adults and to better understand vaccine hesitancy in the Japanese context. The VALUE Initiative and its grantees will together contribute important evidence of how to extend the benefits of immunization to older adults at a critical global moment where immunizing adults is central and essential to relief from the Covid-19 pandemic.

The first VALUE project to launch, Moving the needle, Improving uptake of adult vaccination in Japan, is an innovative ethnographic initiative led by the International Longevity Centre – UK (ILC) and Stripe Partners.

“We are honored and delighted to see our first grantee – the ILC-UK and Stripe Partners – beginning work on their project, which is designed to increase the uptake of vaccinations for people aged 65 and over in Japan,” said Michael Hodin, CEO Global Coalition on Aging.  “When we conceived this grant program back in 2019 with Pfizer Global Medical Grants, we knew of the huge need to enhance adult vaccines as a critical part of prevention-focused health strategies in Japan, and therefore as a model for global lessons, especially as the WHO and UN were planning their launch of the Decade of Healthy Ageing.  And, now with older adults most at risk of severe illness and death from Covid-19 and the attendant need for their immunization, the importance of the program takes on an even greater sense of urgency.”

Immediate action is critical, especially as there will soon be 2 billion globally over 60, and, for the first time in the history of humanity, more old than young. When vaccines are not utilized or under-utilized, the result is an increased vulnerability to several diseases – including shingles, pneumococcal disease, and influenza. As we age, vaccinations can improve quality of life by reducing risks for morbidity and disability and have the potential to increase life expectancy, while having positive impacts on healthcare costs, especially hospitalization, readmissions and physician visits.

“VALUE is a very exciting initiative and a great example of the positive outcomes we can achieve through public/private partnerships,” said Dr. John Beard, Chair of the Global Coalition on Aging Advisory Council, former Director of Ageing and Life Course at the WHO, and member of the Expert Panel that evaluated grant proposals for the VALUE Initiative. “Linking VALUE to global interests in healthy and active aging through the WHO Decade of Healthy Ageing will enable us to learn from Japan even as this initiative contributes to better outcomes for Japan’s aging population itself.”

Along with Dr. Beard and Mr. Hodin, the VALUE Expert Panel includes Dr. Mitsunobu Kano, Okayama University; Dr. Bennett Lee, Pfizer Japan; Dr. Stefania Maggi, European Interdisciplinary Council on Aging; Dr. Kenji Shibuya, King’s College London; and Professor Brigita Skela-Savič, International Council of Nurses.

“By working in partnership with government leaders, NGOs, and professional health and medical associations, the VALUE Initiative will bring greater attention to the need, opportunity, and pathways for solutions and uncover strategies that can measurably increase the number of older adults who are immunized against preventable diseases,” said Hodin. “It is our hope that Japan can become a model for healthier longevity that developed and developing countries alike can follow.”

About Pfizer Global Medical Grants

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

New Index Ranking 11 Countries’ Ability to Tackle Rising Threat of Resistance to Antimicrobials Shows Need for Urgent Action

New York, NEW YORK and Washington, DC (June 23, 2021) – Today the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the first-ever global AMR Preparedness Index, a first-of-its-kind evaluation of how the governments of the 11 largest global economies are living up to their commitments to address antimicrobial resistance (AMR).

Global Alliance on Heart Failure & Healthy Aging Unveils New Report Projecting Sharp Rise in Heart Failure Mortality Linked to Population Aging and Missed or Late Diagnosis

New York, NY – June 10, 2021 – Today, the Global Alliance on Heart Failure and Healthy Aging unveiled a new report, Undiagnosed Heart Failure: A Growing Public Health Risk and Looming Financial Iceberg for Aging Societies. The report examines the link between aging and heart failure, recognizing that a significant portion of heart failure deaths occurs in the older population.

Ageism: how age discrimination can be fought in society and the workplace – but older people have to stop believing the stereotypes first

Ageism is something that’s likely to affect everybody as they grow older and it should be treated as seriously as other “isms”, such as racism and sexism. That was the main takeaway from a recent “Solutions to Combat Ageism” webinar, organised in New York by the Global Coalition on Ageing, which aims to educate and drive change to improve older people’s health, productivity and social engagement.

NEW REPORT – Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era

New York and Tokyo (February 24, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key takeaways from their roundtable on healthy aging, innovation, and the silver economy. The October 2020 virtual roundtable convened experts from across the health, business, aging, and elder homecare sectors in a policy discussion to call on governments to recognize health spending as a critical investment for countries like Japan, who are leading the global megatrend of aging and placing innovation at the center of this investment.

Global Coalition on Aging Partners with the World Summit on the Information Society (WSIS) Forum 2021

New York, NEW YORK (February 23, 2021) – The World Summit on the Information Society (WSIS) Forum 2021 and the Global Coalition on Aging (GCOA) announce their collaboration on the first-ever WSIS Forum Healthy Ageing Innovation Prize to be awarded  at the WSIS Forum 2021.  The prize will be awarded to the most innovative technology that enables healthier and more active ageing and will be presented in parallel with the WSIS Forum 2021 Special Track on ICTs and Older Persons, which is designed, organized and supported by GCOA.

NEW REPORT – The Threat of AMR to Japan’s Super-Aging Society: Implications on Health Care, Public Policy, and Economic Well-Being

New York and Tokyo (February 21, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key policy-focused takeaways from their roundtable on antimicrobial resistance (AMR) in super-aging Japan. On October 7, 2020, the roundtable convened experts from across the business, government, academic, aging, and non-profit sectors in a policy discussion that recognized the multifaceted risks of AMR in aging societies around the world, including super-aging Japan.

WSIS Forum 2021 and the Global Coalition on Aging Partner on Hackathon to Inspire Cutting-Edge ICT Innovation for Older Persons

New York, NEW YORK (February 18, 2021) – The World Summit on the Information Society (WSIS) and the Global Coalition on Aging (GCOA) today announce their partnership on the Ageing Better Through ICTs hackathon, a first-of-its-kind global hackathon focused on innovation for the Silver Economy. The hackathon, conducted virtually, will draw participants from around the world and of all ages to generate ideas for information and communication technologies (ICTs) to improve the lives of older persons.

​​​​Global Coalition on Aging and Pfizer Medical Grants Partner to Tackle Vaccine Hesitancy in Super-Aging Japan

New York, NEW YORK (February 17, 2021) – The Global Coalition on Aging and Pfizer Global Medical Grants announced today the launch of the first of its grant projects under the Japan-focused VALUE Initiative (Vaccines for All: Longevity Unleashed for Everyone), which has provided up to $1 million USD in grant awards. Grant recipients include Keio University, the Health and Global Policy Institute (HGPI), and the International Longevity Centre-UK.

Cross-Sector Panel of Experts Offers Trusted Guidance and Answers New Yorkers’ Questions on the Importance of Older Adult New Yorkers Getting Vaccinated Against Covid-19

New York, NEW YORK (January 21, 2021) – The New York City Department for the Aging, the Age-friendly NYC Commission, and the Global Coalition on Aging (GCOA), the world's leading business voice on aging, collaborated yesterday on a webinar to help build trust and acceptance of the Covid-19 vaccines for New York’s older adults.